However, validated ELISpot assays of influenza-specific CD4 + T cells from infected mice using a variety of antigen presenting cells, including primary dendritic cells, revealed no detectable macroautophagy-dependent component. In contrast, the contribution of proteasome-dependent endogenous antigen processing to the global influenza CD4 + response was readily appreciated. The contribution of macroautophagy to the MHC class II restricted response may vary depending upon the pathogen.
INTRODUCTION

Activation of CD4
+ T cells depends upon their recognition of peptides (epitopes) associated with major histocompatibility class (MHC) class II molecules. Conventionally, peptide generation involves the degradation of exogenous (extracellular) antigens in the endosomal network by multiple mechanisms including unfolding, reduction and proteolytic degradation. It is now clear that epitopes derived from endogenous antigens (synthesized by the cell) can also be presented on MHC class II molecules (12, 22, 24, 38, 49, 50, 60, 66) . Indeed, endogenous antigen expression appears to be an absolute requirement for the presentation of some epitopes. For example, UV inactivation of A/PR8/34 influenza virus (PR8) or treatment of infected antigen-presenting cells (APCs)
with protein synthesis inhibitors prevents presentation of the NA79 epitope (12) . Similar observations have been made for an epitope derived from influenza matrix protein 1 (24) and an epitope derived from the MHC class I H2-L d molecule (39) .
Numerous studies have now demonstrated that endogenous antigens can gain access to MHC class II loading compartments via a variety of intracellular pathways (4, 38, 49, 57, 66, 67) . Perhaps the most straightforward route is autophagy, in which cytosolic proteins are delivered to the lysosome via several different mechanisms.
Chaperone-mediated autophagy results in delivery of cytosolic proteins directly to the lysosome based upon the recognition of a "KFERQ" pentapeptide motif within the target protein, and was shown to be responsible for the presentation of an epitope derived from glutamate decarboxylase (72) . Although 30 % of cytosolic proteins contain this motif (70) , CMA has not yet been implicated in the class II-restricted response to an infectious agent. Macroautophagy is characterized by the formation of a double membrane structure that engulfs portions of the cytosol including proteins, organelles and/or invading pathogens. The resultant autophagosomes undergo membrane fusion with lysosomes and rapid degradation of the contents ensues (18) . Macroautophagic vesicles fuse continuously with class II positive compartments (60) and several epitopes have been shown to depend upon macroautophagy for class II-restricted presentation, including those derived from the C5 protein of the complement pathway (2), neomycin phosphotransferase (45, 53) and the Epstein Barr virus Nuclear Antigen 1 (EBNA-1) (35, 50) . Interestingly, EBNA-1 contains two class II-restricted endogenous epitopes that are not autophagy dependent, suggesting that this protein can be processed via more than one pathway (35) . Other studies of macroautophagy in antigen processing have employed engineered model antigens in which a well-defined epitope is affixed to a protein that naturally localizes to the autophagosome. For example, autophagy-dependent presentation was demonstrated for an influenza matrix protein 1 derived epitope fused to the LC3B protein that is involved in autophagosome formation (60) .
While a contribution by macroautophagy to class II processing is intuitively appealing, several considerations complicate the picture: 1) In many cases the aggressive proteolysis associated with autophagy may be counterproductive for antigen processing.
Presentation of many epitopes is diminished or ablated with elevated endosomal proteolysis (6, 58) . Likewise, it has been reported that dendritic cells with reduced endosomal proteolytic activity are more efficient antigen presenters (6, 58) . 2) Results that suggest a role for autophagy may have alternative explanations. For example, autophagy was implicated in the class II restricted presentation of antigens derived from nuclear and cytosolic proteins (8) due to the positive effects of serum starvation but this condition also enhances proteasomal activity (14) . In addition, gene ablation of a key autophagy component has been reported to impact not just autophagy, but the presentation of exogenous antigens as well (1, 34) . 3) Some autophagy substrates may be atypical. For example, EBNA-1 is unusual in containing a Glycine-Alanine (Gly-Ala)
repeat region that appears to be involved in immune evasion (36, 37) and also renders the protein prone to aggregation (19, 40) thereby increasing its susceptibility to autophagy (52, 68) . 4) Finally, in studying the presentation of class II-restricted epitopes from the influenza neuraminidase and hemagglutinin (HA) glycoproteins, our laboratory has identified an endogenous pathway that depends upon the multicatalytic proteasome, the macromolecular complex that is responsible for most protein turnover within the cytosol and nucleus (13, 17, 20) . Remarkably, ELISpot assays revealed that 30-40% of the total MHC class II restricted response to influenza is specific for proteasome-dependent epitopes (66), a fraction that, when added to the contribution of exogenous processing, may largely discount other processing pathways. Thus, elucidating the relative roles of various processing pathways will require a more global approach.
Here we have taken such a global approach in assessing the CD4 + T cell responses to influenza virus infection. Although influenza infection activates functional autophagy and we were able to detect autophagy dependent presentation with engineered processing substrates, we could discern no significant contribution of this pathway to the CD4 + T cell response. For plasmid generation, the S1 epitope was inserted at the C terminus of Neomycin phosphotransferase or the N terminus of LC3B by PCR using primers that encoded for the S1 epitope at the indicated position. The PCR product was inserted into the pGEM T Easy vector (Thermo Fisher Scientific) and subsequently cloned into the pMSCV vector (generous gift of Dr. Jianke Zhang, Thomas Jefferson University). All DNA constructs were verified by sequencing.
MATERIALS AND METHODS
Cells
The influenza viruses A/PR/8/34 (PR8; H1N1), A/Japan/305/57 (Jap; H2N2), and B/Lee/40 (B/Lee) were grown as previously described (66) . For experiments involving UV virus, live PR8 was diluted in PBS and subjected to UV light for 10 minutes with gentle shaking. Inactivation of the virus was confirmed by staining fibroblasts pulsed with UV PR8 virus for influenza proteins via flow cytometry. Viral titers were determined using chicken red blood cells and were expressed in hemagglutinin units (HAU). Adenovirus expressing S1LC3 (Ad-S1LC3) was generated by cloning the S1LC3 construct into the pENTR4 entry vector (Invitrogen), followed by subcloning into pAd/CMV/V5-DEST (Invitrogen). Virus was produced in 293A cells (Invitrogen) by transfection with linearized S1LC3-pAd/CMV/V5, followed by expansion and purification with the Adeno-X Purification Kit according to manufacturer's recommendations (BD Biosciences, San Jose CA). for 15 minutes at room temperature, washed extensively and cultured overnight with S1 T hybridomas. T cell activation was assessed by measuring beta-galactosidase activity using the fluorescent substrate 4-methylumbelliferyl ß-D-glucuronide (MUG) with the amount of fluorescence being directly proportional to T cell activation (56, 62) .
Mice
For chemical inhibition, the autophagy construct S1LC3 was transfected into B6-IEd as described above. Twenty four hours later the cells were washed in PBS, acid washed to remove existing pMHC-II complexes from the surface, washed extensively and cultured overnight in the presentence of 3MA (Sigma Aldrich) or wortmannin (EMD Biosciences). Cells were harvested and cultured for 6 hours with S1 T hybridomas in a MUG assay. For siRNA mediated inhibition, the autophagy construct S1LC3 was stably transfected into B6-IEd and siRNA was transfected as described above. Cells were harvested and cultured with S1 T hybridomas overnight in a MUG assay.
ELISpots. L-IEd or B6-IEd fibroblasts, A20 B cell lymphoma, RAW264.7 macrophages or primary BMDCs were transfected/transduced with the indicated siRNAs or shRNAs.
After the optimal time periods for maximal knockdown, the cells were harvested and 
RESULTS
Influenza infection induces functional macroautophagy. Autophagy can be induced by a variety of viral and bacterial infections (26, 30, 48) . Two recent publications reported that influenza virus infection can induce autophagy (15, 73) , however one of these indicated that the process is incomplete due to inhibition of vesicular fusion (15) . To explore autophagy induction and maturation in our system, L929 fibroblasts stably Atg7 siRNA had a similar impact when rapamycin was used to induce autophagy (data not shown).
To determine whether macroautophagy progressed to maturation we generated B6-IEd fibroblasts that stably express a GFP-LC3 fusion construct (42) . Autophagy induction via PR8 infection in B6-IEd-GFP-LC3 cells resulted in a significant decrease in GFP fluorescence (Fig. 2a left panel) , reflecting successful fusion of the autophagosome and destruction of the contents (61) . Reduction in fluorescence was not observed in cells expressing unconjugated GFP (Fig. 2a right panel) . Furthermore, chemical inhibition of autophagy via wortmannin prevented the reduction of GFP levels after influenza virus infection (Fig. 2b) as well as the accumulation of endogenous LC3-II (Fig. 2c) . In addition, PR8 infection of L-IEd fibroblasts resulted in decreased levels of p62, a protein specifically degraded by the autophagy pathway (51) (data not shown). Together these results indicate that the cell lines used for subsequent experiments are capable of being induced to functional autophagy by influenza infection and that our methods of silencing this process are effective.
Autophagy can contribute to the presentation of endogenous antigens on MHC class II molecules. We next determined whether autophagy can deliver endogenous antigens for epitope presentation to CD4 + T cells as has been previously described (8, 23, 34, 45, 50, 53) . To this end, we appended the classically presented H2-IEd restricted Site 1 (S1) epitope of influenza hemagglutinin, which appears to have innate resistance to endocytic proteases (3, 11) to two proteins that have been well described to localize naturally to the autophagosome. S1-conjugated neomycin phosphotransferase (C-terminal attachment) or S1-conjugated LC3B (N-terminal attachment) were transiently transfected into B6-IEd fibroblasts and S1 presentation was assessed using S1-specific T cell hybridomas. As shown in Figure 3 , the S1 epitope was presented efficiently from both constructs compared to mock transfected controls. T cell stimulation was enhanced when cells expressing either construct were treated with rapamycin, consistent with an autophagy dependent mechanism of presentation. The more dramatic response of the S1LC3 construct is likely due to LC3B being a specific component of the autophagy pathway whereas NeoS1 is an autophagy substrate that may be less efficiently incorporated into the autophagosome.
Overnight treatment of S1LC3 expressing cells with the chemical inhibitors of autophagy 3MA or wortmannin significantly reduced the presentation of the S1 epitope from B6-IEd fibroblasts (Fig. 4a) . 3MA treatment inhibited S1 presentation to a greater extent than wortmannin; however it was also observed to be more toxic to the cells in culture (data not shown). Atg7 siRNA transfection of B6IEd cells stably expressing S1LC3 also resulted in decreased S1 presentation compared to control siRNA transfected cells (Fig. 4b) . Additionally, we mutated the glycine at residue 120 of LC3 to an alanine, which prevents LC3 conversion (25) . This substantially reduced S1 presentation from the fusion protein (see Fig. S1 in the supplemental material).
Establishing a system to assess the contribution of autophagy to the CD4 + T cell response to influenza. To determine the contribution of autophagy to the in vivo influenza-specific CD4 + T cell responses, we elected to use an assay that we previously developed for assessing the influence of proteasome activity on the magnitude of the CD4 + T cell response (66) . This involved infection of wild-type mice and analyzing the resulting CD4 + T cell response with an interferon-γ ELISpot in which influenza-infected stimulator cells were treated with or without proteasome inhibitor. The difference in spot number reflected the number of T cells specific for proteasome-dependent epitopes. Even if proteasome deficient mice had been available, we would have chosen this configuration rather than comparing responses in infected wild-type and knockout mice.
Our rationale was that the limited homeostatic space might have allowed greater and lesser quantities of naïve T cells in the wild-type and knockout mice to expand to the same absolute numbers. Thus, although mice have been generated with autophagy deficiencies in certain cell types (34), we opted to dissect the response that occurs in wild-type mice. Aiding this decision was the report that DCs from these knockout mice appear to be impaired in exogenous antigen processing as well (34) . To ensure that the assay was sufficiently sensitive, we determined the change in the responding T cell population that can be statistically detected. BALB/c mice were primed with either PR8
or B-Lee influenza viruses which are immunologically distinct. Ten days after priming, CD4 + T cells were isolated from the spleens, mixed in different proportions and cultured with L-IEd fibroblasts infected with either PR8 or B-Lee virus. Antigen specific CD4 + T cell responses above background were detected when 10% of the total T cell population was specific for the restimulating virus (see Fig. S2 in the supplemental material).
Also in preparation for analysis of the in vivo response, we constructed a positive control adenovirus that expresses S1LC3 (Adeno-S1LC3). We immunized mice intranasally with live PR8 virus and at least 10 days after immunization isolated CD4 + T cells from the spleen via negative selection. Under these conditions, the S1 epitope is immunodominant (21) . The CD4 + T cells isolated from influenza primed mice were cultured with siRNA transfected L-IEd fibroblasts infected with Adeno-S1LC3 virus.
Because only S1 is shared between the two viruses, only S1 specific T cells respond in the assay. Atg7 knockdown in Adeno-S1LC3 infected L-IEd fibroblasts significantly reduced the number of responding CD4 + T cells in an IFN-γ ELISpot assay (Fig. 4c) . A decrease in S1 specific T cell activation in an in vitro T hybridoma assay (Fig. 4d) (Fig. 4c) and sensitivity of the assay, Atg7 siRNA had no detectable effect on the number of responding CD4 + T cells ( Fig. 5a-d) . Similar results were obtained utilizing intraperiotenal or intranasal routes of immunization and also when limiting doses of influenza were used both for priming and for infection of the antigen presenting cells (Fig 5a vs. c and 5b Furthermore, stimulation of influenza specific CD4 + T cells with DCs infected with live virus resulted in higher amounts of T cell activation than when UV inactivated virus was used (data not shown), again indicating that the a substantial portion of the class II response is directed against endogenous epitopes. Knockdown of Atg7 in GFP hi cells was substantial ( Fig 6A) and this resulted in functionally impaired autophagy as reflected by p62 accumulation (Fig 6B) . As with all the other cell types tested,, these primary DCs demonstrated no significant contribution of the macroautophagy pathway to in vivo CD4 + T cell activation (Fig 6C) . Importantly, in contrast to Atg5 deficient DCs (34), the presentation of exogenous antigens in our system was not affected (see Fig S6 A ,B in supplemental material).
As previously reported (66), treatment of stimulatory APCs with the proteasome inhibitor epoxomicin resulted in a significant decrease in the number of CD4 + T cells responding in the ELISpot assay (Fig. 7a, b) . This was not due to non-specific effects of epoxomicin as presentation of synthetic peptide and the classically presented S1 epitope were not affected. Additionally, while inhibition of protein translation is a potential offtarget effect of proteasome inhibitors, production of influenza proteins was only marginally inhibited (see Fig. S7 in the supplemental material). In order to further substantiate the contribution of proteasome-dependent processing and to obtain a closer comparison with our autophagy related results we carried out siRNA knockdown of Rpt2, an ATPase subunit of the 19S regulatory cap of the proteasome (54) . The impact on the ELISpot assay was comparable to that of epoxomicin treatment (without an effect on protein synthesis), while siRNA inhibition of Atg7again had no effect (Fig. 7c,d ).
In summary, although we were able to demonstrate autophagy dependent presentation of individual epitopes, both after transfection and viral infection, we were unable to detect a significant contribution of this pathway to the global presentation of class II restricted epitopes derived from influenza virus infection. At the same time, we did observe a significant contribution of the proteasome dependent pathway to the global class II-restricted response using two different approaches. These results reinforce the notion that, at least for influenza virus, the majority of the endogenous epitopes presented on MHC class II are processed via proteasome-dependent pathway(s).
DISCUSSION
With recent work highlighting the potential for macroautophagy to orchestrate endogenous MHC class II-restricted presentation of individual antigens (16, 35, 44, 45, 50, 60) , our goal was to determine the role in the CD4 + T cell response to a complex pathogen, specifically influenza. We focused upon this virus due to our previous elucidation of a proteasome-dependent endogenous pathway that is responsible for a substantial portion of the class II-restricted response to influenza infection (66) .
Considering the large contribution that the classical exogenous pathway also makes to the response, we wondered if there would be sufficient opportunity for another major pathway. Before addressing this central question, preliminary work in three general areas was required to validate both the relevance of studying autophagy in the context of an influenza infection and the experimental system that we had selected.
First, although influenza virus infection has been shown to induce LC3 conversion in a number of cell lines, it remains unclear whether functional autophagy, resulting in membrane fusion with active lysosomes, is stimulated (15, 33, 73) . It has been reported that influenza infection of human lung epithelial cells prevents autophagosomes from fusing with lysosomes (15) with the viral M2 protein acting as an inhibitor of Beclin-1, a key protein in the autophagy pathway. However, others have concluded that functional autophagy, as measured by the degradation of the autophagy substrate p62, does occur in the face of influenza infection (33) . The discrepancies may be due to the cell types and/or the influenza strains that were utilized. As assessed by both GFP-LC3 and p62 degradation, we observed that influenza virus infection does induce functional macroautophagy in several different cell types, including primary DCs, with no detectable block in the pathway.
Second, using a standard approach in the field, we ascertained our ability to observe macroautophagy dependent antigen processing by tracking presentation of an individual epitope (2, 35, 45, 50) . Appending the S1 epitope onto neomycin phosphotransferase or LC3B and expressing the constructs via transfection resulted in autophagy dependent presentation that could be enhanced by inducing autophagy with rapamycin or significantly decreased by chemical and genetic inhibition of the autophagy pathway. We also constructed an adenovirus expressing the S1LC3 fusion protein and obtained similar results.
Third, we utilized a recombinant adenovirus to validate the ELISpot assay that Our results demonstrate that short-term knockdown of autophagy, in contrast, does not have this effect.
Having carried out these preliminary steps, we asked whether macroautophagy plays a major role in the generation of epitopes during influenza virus infection. Despite potent induction of functional autophagy by influenza virus infection and a sufficiently sensitive assay, we detected no significant contribution of this pathway to the global CD4 + T cell response to influenza virus. This was true of all antigen presenting cell types tested including primary DCs and also when the assay was restricted to the internal and non-structural proteins of the virus. In contrast, as previously reported (66) a substantial portion of the CD4 + T cell response was observed to be proteasome-dependent by two independent methods for modulating proteasome activity (chemical inhibition and siRNA treatment).
Several factors may limit the utility of autophagy for class II-restricted epitope generation. Although largely considered a nonselective pathway of protein degradation, recent data suggest that efficient delivery of individual soluble proteins to the autophagosomes is dependent upon a specific recognition mechanism (27, 29, 46) . In agreement with this, the S1 epitope is more robustly presented from the S1LC3 construct, which is directly targeted to the autophagy pathway via LC3B, compared to the NeoS1 construct, which is likely targeted by less selective mechanisms. It seems unlikely that individual viral proteins would self target to this compartment, as has been reported in some cases (69) , unless it were advantageous. Both poliovirus and rhinovirus induce the formation of double membrane autophagosomes to facilitate replication and autophagy inhibition via siRNA was observed to decrease the amount of poliovirus released from infected cells. Indeed, conditions necessary for processing are likely absent since induced autophagosomes are not mobile and presumably do not fuse efficiently with the late endosome compartment (65) . Likewise, hepatitis C virus induces autophagy to initiate the early stages of viral replication (9, 10, 64) but the degradation of autophagy substrates, including p62, is blocked (63) .
Once captured by the autophagosome, an epitope must survive in the highly proteolytic environment of the late endosome/lysosome. This may be a losing prospect in many cases. Enhanced proteolytic activity has been reported to be generally detrimental to antigen presentation, consistent with the idea that proteases and empty class II molecules compete for access to unfolded proteins (7, 59) . What is more, autophagy inhibition via siRNA has been reported to reduce cathepsin activity in the late endosome (34) , suggesting that fusion of the autophagosome with the endosomal compartment may create an even more aggressive environment. We have previously reported on the negative impact of heightened proteolysis. Presentation of the hemagglutinin-based S3
epitope from exogenous sources of PR8 is enhanced up to ten-fold when endosomal cathepsins are inhibited (3), while the NA79 epitopes appears to be so susceptible to endosomal proteases that presentation from exogenous virus is undetectable in most cases (11, 66) . In contrast to S1, neither of these epitopes was presented when appended to neomycin phosphotransferase with or without rapamycin treatment (data not shown), suggesting that they are immediately destroyed upon delivery to the autophagosome.
Thus, only those class II-restricted epitopes that are sufficiently resistant to endolysosomal proteolysis, may be candidates for autophagy mediated presentation.
We cannot rule out the possibility that there is a small autophagy-dependent fraction of the class II-restricted influenza response that is below the detection limit of our assays. In our system, we determined the sensitivity of the ELISpot assay to detect antigen specific T cells to be <10%, suggesting that if autophagy does play a role in the class II response, the contribution is minimal. In addition we cannot discount the possibility that epitopes are generated via parallel pathways such that inhibition of autophagy would shift the substrate to other processing routes.
In preliminary experiments the global class II responses to vaccinia and adenovirus infections are also not substantially altered by inhibition of autophagy (J.D.C.
unpublished observations). We are, nevertheless, cautious about generalizing these findings to other viruses. All three of the viruses that have been tested mediate acute and limiting infections in mice. In contrast, herpes viruses such as EBV are generally chronic and evasion from CD8 + T cell recognition appears to be a major priority (5) . The EBNA-1 protein contributes directly to this effort by blocking proteasomal degradation and subsequent MHC class I restricted presentation via an N-terminal Gly-Ala repeat (36, 37) . Other herpes viruses encode proteins with similar functions (31, 71) . Inhibition of the proteasome induces aggregate formation which may shift the balance of global protein degradation towards the autophagy pathway (28, 32, 68) . Thus similar analyses of viruses with fundamentally different replication strategies are warranted
